Assessing the role of ustekinumab dose escalation in Crohn's disease patients with loss of response: an observational study
{{output}}
Background/aims: Among Crohn's disease patients with loss of response or non-response to ustekinumab (UST), there remains no clear strategy for dose escalation. Moreover, clinical associations and the role of therapeutic drug mo... ...
